Gene: BLZF1
Official Full Name: basic leucine zipper nuclear factor 1provided by HGNC
Gene Summary: Enables ubiquitin protein ligase binding activity. Acts upstream of or within Golgi organization and Golgi to plasma membrane protein transport. Located in Golgi apparatus and nucleoplasm. Biomarker of hepatocellular carcinoma. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34061 | BLZF1 Knockout cell line (HeLa) | Human | BLZF1 | 1:3~1:6 | Negative | Online Inquiry |
KO34062 | BLZF1 Knockout cell line (HCT 116) | Human | BLZF1 | 1:2~1:4 | Negative | Online Inquiry |
KO34063 | BLZF1 Knockout cell line (HEK293) | Human | BLZF1 | 1:3~1:6 | Negative | Online Inquiry |
KO34064 | BLZF1 Knockout cell line (A549) | Human | BLZF1 | 1:3~1:4 | Negative | Online Inquiry |
BLZF1 Gene Knockout Cell Lines represent a significant advancement in genetic research, specifically tailored for the study of the BLZF1 gene's functions. These cell lines are genetically engineered to disrupt the BLZF1 gene, allowing researchers to elucidate its role in various biological processes and disease mechanisms. By harnessing CRISPR-Cas9 technology or similar gene-editing techniques, these knockout cell lines provide a platform for investigating gene function, cellular pathways, and the molecular basis of disorders associated with BLZF1 dysregulation.
The primary function of these cell lines is to serve as a robust model system for functional assays, including pathway analysis, drug testing, and genetic interaction studies. The absence of the BLZF1 protein enables scientists to observe resultant phenotypic changes and alterations in cellular signaling cascades, thereby offering insights into gene interplay and pathway dynamics.
From a scientific perspective, BLZF1 Gene Knockout Cell Lines are invaluable for exploring the implications of BLZF1 in immune response, inflammation, and its potential role in oncogenesis. Their applications extend to both academic research and therapeutic development, including the optimization of interventions targeting related conditions. By providing a clear view of gene function and cellular behavior in the context of knockout genetics, these cell lines facilitate groundbreaking research that could lead to novel therapeutic approaches.
One of the standout advantages of our BLZF1 Gene Knockout Cell Lines is their high specificity and reliability compared to other knockout systems, such as those relying on transient transfection methods, which often lead to inconsistent expression profiles. Our cell lines are rigorously validated for efficient gene disruption, ensuring reproducibility and accuracy in experimental outcomes.
For researchers and clinicians seeking to deepen their understanding of gene function and its clinical implications, our BLZF1 Gene Knockout Cell Lines offer an unparalleled resource. With a commitment to quality and innovation in biotechnology, our company is dedicated to equipping scientists with the necessary tools to advance their research and clinical endeavors effectively.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.